Understand any stock in simple English
Organigram grows and sells cannabis products to recreational users and medical patients in Canada and abroad.
Organigram is a Canadian cannabis company. It grows marijuana and turns it into the products people actually buy: dried flower for smoking, pre-rolled joints, vapes, oils, and edible-style products. It sells these to two very different customers. One is the adult who walks into a legal weed store or orders online for fun. The other is a medical patient who uses cannabis for health reasons and often buys through the company's own direct channels, which tends to be a steadier, more loyal business than the recreational market.

The recreational side is a brutal business to be in. Canada legalized cannabis for adults in 2018, and a gold rush followed. Too many companies built too much growing capacity, the black market kept a big chunk of customers, and prices fell hard. Organigram survived that shakeout better than many rivals because it kept its costs low and its balance sheet relatively clean. Its edge is a low-cost growing operation in Moncton, New Brunswick, plus a habit of staying disciplined while competitors overspent. What makes Organigram interesting right now is that it stopped trying to win Canada alone. It has been buying and partnering its way into international markets, where medical cannabis is legal in more places and margins can be fatter. Its biggest move was a deal with British American Tobacco, the giant cigarette maker British American Tobacco, which took a large stake in Organigram and works with it on new product research. That partnership gave Organigram cash and a powerful ally, and it signals that Big Tobacco sees a future in cannabis.
The company still loses money and the sector remains risky, so this is not a sleepy dividend stock. It is a bet that a lean Canadian grower can build a global cannabis brand while the industry matures. Investors should watch whether international sales and the tobacco partnership turn into real, repeatable profit, because the Canadian recreational market alone is a tough way to make a living.
Saved answer · last researched 17 Nov 2026